Asundexian versus Apixaban in Patients with Atrial Fibrillation

被引：0
|
作者：
Straw, Sam
Witte, Klaus K.
Philippou, Helen
Benkhoff, Marcel
Mourikis, Philipp
Polzin, Amin
Piccini, Jonathan P.
Patel, Manesh R.
Caso, Valeria
机构：
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2025年 / 392卷 / 12期
关键词：
PLATELET ACTIVATION; RIVAROXABAN; PREVENTION; TRIAL;
D O I：
10.1056/NEJMc2501201
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Asundexian versus Apixaban in Patients with Atrial Fibrillation
    Piccini, Jonathan P.
    Patel, Manesh R.
    Steffel, Jan
    Ferdinand, Keith
    Van Gelder, Isabelle C.
    Russo, Andrea M.
    Ma, Chang-Sheng
    Goodman, Shaun G.
    Oldgren, Jonas
    Hammett, Christopher
    Lopes, Renato D.
    Akao, Masaharu
    De Caterina, Raffaele
    Kirchhof, Paulus
    Gorog, Diana A.
    Hemels, Martin
    Rienstra, Michiel
    Jones, W. Schuyler
    Harrington, Josephine
    Lip, Gregory Y. H.
    Ellis, Stephen J.
    Rockhold, Frank W.
    Neumann, Christoph
    Alexander, John H.
    Viethen, Thomas
    Hung, James
    Coppolecchia, Rosa
    Mundl, Hardi
    Caso, Valeria
    NEW ENGLAND JOURNAL OF MEDICINE, 2025, 392 (01): : 23 - 32
  • [2] Apixaban versus Warfarin in Patients with Atrial Fibrillation
    Granger, Christopher B.
    Alexander, John H.
    McMurray, John J. V.
    Lopes, Renato D.
    Hylek, Elaine M.
    Hanna, Michael
    Al-Khalidi, Hussein R.
    Ansell, Jack
    Atar, Dan
    Avezum, Alvaro
    Cecilia Bahit, M.
    Diaz, Rafael
    Easton, J. Donald
    Ezekowitz, Justin A.
    Flaker, Greg
    Garcia, David
    Geraldes, Margarida
    Gersh, Bernard J.
    Golitsyn, Sergey
    Goto, Shinya
    Hermosillo, Antonio G.
    Hohnloser, Stefan H.
    Horowitz, John
    Mohan, Puneet
    Jansky, Petr
    Lewis, Basil S.
    Luis Lopez-Sendon, Jose
    Pais, Prem
    Parkhomenko, Alexander
    Verheugt, Freek W. A.
    Zhu, Jun
    Wallentin, Lars
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (11): : 981 - 992
  • [3] Critique of Apixaban Versus Warfarin in Patients With Atrial Fibrillation
    Nedeltchev, Krassen
    STROKE, 2012, 43 (03) : 922 - 923
  • [4] Asundexian reduces haemorrhage versus apixaban
    Reactions Weekly, 2022, 1902 (1) : 4 - 4
  • [5] Apixaban versus Warfarin in Atrial Fibrillation
    Simini, Bruno
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (01): : 88 - 89
  • [6] Apixaban in Patients with Atrial Fibrillation
    Connolly, Stuart J.
    Eikelboom, John
    Joyner, Campbell
    Diener, Hans-Christoph
    Hart, Robert
    Golitsyn, Sergey
    Flaker, Greg
    Avezum, Alvaro
    Hohnloser, Stefan H.
    Diaz, Rafael
    Talajic, Mario
    Zhu, Jun
    Pais, Prem
    Budaj, Andrzej
    Parkhomenko, Alexander
    Jansky, Petr
    Commerford, Patrick
    Tan, Ru San
    Sim, Kui-Hian
    Lewis, Basil S.
    Van Mieghem, Walter
    Lip, Gregory Y. H.
    Kim, Jae Hyung
    Lanas-Zanetti, Fernando
    Gonzalez-Hermosillo, Antonio
    Dans, Antonio L.
    Munawar, Muhammad
    O'Donnell, Martin
    Lawrence, John
    Lewis, Gayle
    Afzal, Rizwan
    Yusuf, Salim
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (09): : 806 - 817
  • [7] Apixaban versus warfarin in patients with atrial fibrillation: examination of ARISTOTLE
    Szczerba, Ewa
    KARDIOLOGIA POLSKA, 2012, 70 (02) : 196 - 200
  • [8] Outcomes of Apixaban Versus Rivaroxaban in Patients With Nonvalvular Atrial Fibrillation
    Jehle, D.
    Paul, K.
    Sorensen, B.
    ANNALS OF EMERGENCY MEDICINE, 2024, 84 (04) : S9 - S9
  • [9] Effectiveness and Safety of Apixaban Versus Rivaroxaban for Patients With Atrial Fibrillation
    不详
    ANNALS OF INTERNAL MEDICINE, 2020, 172 (07) : 463 - 473
  • [10] Apixaban in Patients with Atrial Fibrillation
    Lynch, Donald R., Jr.
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (24): : 2362 - 2363
12345